| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/22/2002 | CA2437122A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | CA2436371A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2436195A1 Laulimalide derivatives |
| 08/22/2002 | CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2434982A1 Pyridine matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2433778A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2433075A1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1233023A1 Transcription factor and dna thereof |
| 08/21/2002 | EP1233018A2 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1233017A1 Tricyclic sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1233016A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1233013A1 Novel phenylalanine derivatives |
| 08/21/2002 | EP1232263A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232259A1 Human galanin family proteins and polynucleotides encoding the same |
| 08/21/2002 | EP1232179A1 15 human secreted proteins |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 08/21/2002 | EP1232158A1 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 08/21/2002 | EP1232155A1 Protease inhibitors |
| 08/21/2002 | EP1232154A1 Protease inhibitors |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1232144A2 Novel il-8 receptor antagonists |
| 08/21/2002 | EP1232139A1 Nervonic acid derivatives, their preparation and use |
| 08/21/2002 | EP1231982A2 Use of phthalazine derivatives |
| 08/21/2002 | EP1231943A1 Interferon gamma conjugates |
| 08/21/2002 | EP1231937A2 Tr3-specific binding agents and methods for their use |
| 08/21/2002 | EP1231931A2 Methods of treating inflammatory bowel disease using cholera toxin b subunit |
| 08/21/2002 | EP1231930A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 08/21/2002 | EP1231924A2 Treatment of systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 08/21/2002 | EP1231923A1 Protease inhibitors |
| 08/21/2002 | EP1231922A1 Protease inhibitors |
| 08/21/2002 | EP1231921A1 Protease inhibitors |
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP1231887A2 Method and composition for the treatment of scars |
| 08/21/2002 | EP0956034B1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin |
| 08/21/2002 | EP0759757B1 Oral liquid alendronate formulations |
| 08/21/2002 | CN1365360A Puring derivatives inhibitors of tyrosine kinase SYK |
| 08/21/2002 | CN1365281A Metalloprotease inhibitors |
| 08/21/2002 | CN1364645A Polycaprolactone-brufen composition and its preparation method and use |
| 08/21/2002 | CN1364640A Medicinal wine for curing rheumatic ostealgia and its preparing method |
| 08/21/2002 | CN1364630A Rheumatic pain killing medicine powder |
| 08/21/2002 | CN1364621A Medicinal wine for curing rheumatism, rheumatoid and various diseases caused by wind and cold |
| 08/21/2002 | CN1364618A Rheumatism treating medicine powder |
| 08/21/2002 | CN1364609A External use medicine bag for stagnation-syndrome |
| 08/21/2002 | CN1364601A Nano Chaihuang heat clearing away medicine and its preparing method |
| 08/21/2002 | CN1364597A Nano traumotologic Bali medicine and its preparing method |
| 08/21/2002 | CN1364594A Nano heat clearing away and acne eliminating medicine and its preparing method |
| 08/21/2002 | CN1364584A Nano children Qiying medicine and its preparing method |
| 08/21/2002 | CN1364583A Nano chilren heat clearing away medicine and its preparing method |
| 08/21/2002 | CN1364582A Nano children heat clearing away and cough arresting medicine and its preparing method |
| 08/21/2002 | CN1364581A Nano Children heat fast clearing away medicine and its preparing method |
| 08/21/2002 | CN1364573A Nano Yulian medicine and its preparing method |
| 08/21/2002 | CN1364566A Nano pile fast curing medicine and its preparing method |
| 08/21/2002 | CN1364565A Nano wind-evil expelling medicine and its preparing method |
| 08/21/2002 | CN1364558A Nano wet and heat astralgia treating medicine and its preparing method |
| 08/21/2002 | CN1364527A Nano five ingredient xianglian medicine and its preparing method |
| 08/21/2002 | CN1364518A Nano pittecellobium clypearia Benth anti-imflammatory medicine and its preparing method |
| 08/21/2002 | CN1364500A Nano sanliangban medicine and its preparing method |
| 08/21/2002 | CN1364499A Nano three wonderful medicine and its preparing method |
| 08/21/2002 | CN1364495A Nano traumatologic seven ingredient medicine and its preparing method |
| 08/21/2002 | CN1364494A Nano musk rheumatic medicine and its preparing method |
| 08/21/2002 | CN1364493A Nano musk joint pain stopping medicine and its preparing method |
| 08/21/2002 | CN1364483A Nano medicine for dispelling wind and activating blood flow in channels and collaterals and its preparing method |
| 08/21/2002 | CN1364478A Nano wanyingding medicine and its prepairng method |
| 08/21/2002 | CN1364472A Nano five ingredient musk medicine and its preparing method |
| 08/21/2002 | CN1364463A Berberis poiretii schneid detoxicating and inflammation diminishing tablet and its preparing process |
| 08/21/2002 | CN1089336C Colchicine and thiocolchicine derivatives with anti-inflammatory and muscle relaxant activities |
| 08/21/2002 | CN1089242C Method for extracting active component of sea cock roach |
| 08/21/2002 | CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages |
| 08/20/2002 | US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437148 Intermediates for (R)-3(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one |
| 08/20/2002 | US6437146 Mesangial proliferative glomerulonephritis |
| 08/20/2002 | US6437124 Xanthine derivatives which inhibit expression of adhesion molecules on human umbilical vein endothelial cell (huvec) monolayers at very low concentrations |
| 08/20/2002 | US6437000 Controlled release oral dosage for suitable for oral administration |
| 08/20/2002 | US6436990 Antiinflammatory, rheumatic and antiarthritic agents, having improved transformation; side effect reduction |
| 08/20/2002 | US6436987 Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid |
| 08/20/2002 | US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease |
| 08/20/2002 | US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436942 Enantiomers of 1[(4-chloro-phenyl) phenylmethyl]-4-[(4-methylphenyl) sulfony]piperazine |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |
| 08/20/2002 | US6436911 IL-12 production inhibitor |
| 08/20/2002 | US6436909 Antisense inhibition of transforming growth factor-β expression |
| 08/20/2002 | US6436637 Polynucleotide; expression vector; antiinflammatory agents; cell proliferative and apoptosis disorder treatment |
| 08/20/2002 | US6436438 Tramadol multiple unit formulations |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | US6435873 Medication delivery devices |
| 08/20/2002 | CA2216129C Lactam-containing hydroxamic acids |
| 08/20/2002 | CA2110055C T cell receptor peptides as therapeutics for immune-related disease |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2073983C Novel vitamin d analogues |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063005A2 Lipid-associated molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |